Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Neurooncol. 2017 Jan 23;132(1):181–188. doi: 10.1007/s11060-016-2357-9

Table 3A. Grade 3 and 4 toxicities attributed to aflibercept and temozolomide for Arm 1.

Adverse Event Aflibercept DL0 Aflibercept DL1 Temozolomide (DL0) Temozolomide (DL1)
Abdominal pain 1
Alanine aminotransferase increase 1
Aspartate aminotransferase increase 1
Alkaline phosphatase increase 1
Bilirubin increase 2 1
Gamma glutamyl transferase increase 1
Arthralgia 1 1
Colonic perforation 1
Colitis 1
Dehydration 1
Fatigue 1 1
Headache 1
Hypertension 1
Hypokalemia 1
Hyponatremia 1
Seizure 3 3
Nausea 1
Lung infection 1
Peripheral nerve infection 1
Urinary tract infection 1
Vascular access complication 1 1
Leukopenia 1 1
Lymphopenia 3 4
Neutropenia 2 2
Thrombocytopenia 2 2
Investigations (other) 1